Epidemiology of Stroke

Chapter
Part of the Nutrition and Health book series (NH)

Key Points

  • Stroke is the fourth leading cause of death in the USA, and it is the second leading cause of death worldwide.

  • Although there has been a decline in stroke incidence and mortality in the USA, this trend is not expected to last. With the aging of the population, the incidence and deaths from stroke are likely to skyrocket, and epidemiologists have warned of a stroke epidemic in the next 25 years.

  • Stroke incidence and mortality will increase more quickly in low-income and middle-income countries because of the increases in the prevalence of risk factors for cardiovascular disease, including urbanization and Western-style dietary changes.

Keywords

Epidemiology Stroke Mortality Incidence Intracerebral hemorrhage 

Abbreviations

AF

Atrial Fibrillation

DALYs

Disability Adjusted Life Years

ICH

Intracerebral Hemorrhagic Stroke

SAH

Subarachnoid Hemorrhage

TIA

Transient Ischemic Attack

References

  1. 1.
    Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.PubMedCrossRefGoogle Scholar
  2. 2.
    Goldstein LB, Bushnell CD, Adams RJ, Appel LJ. Braun LT. Chaturvedi S. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517–84.PubMedCrossRefGoogle Scholar
  3. 3.
    Howard VJ, Kleindorfer DO, Judd SE, McClure LA. Safford MM. Rhodes JD, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011;69:619–27.PubMedCrossRefGoogle Scholar
  4. 4.
    Rich DQ, Gaziano JM, Kurth T. Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States. Stroke. 2007;38:2221–7.PubMedCrossRefGoogle Scholar
  5. 5.
    WHO. The global burden of disease: 2004 update, WHO Press, Switzerland, http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (accessed March 25, 2013).
  6. 6.
    Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. 2007;6:94–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011;8:319–29.PubMedCrossRefGoogle Scholar
  9. 9.
    Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet. 2003;362:1211–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–44.PubMedCrossRefGoogle Scholar
  11. 11.
    Elkins JS, Johnston SC. Thirty-year projections for deaths from ischemic stroke in the United States. Stroke. 2003;34:2109–12.PubMedCrossRefGoogle Scholar
  12. 12.
    Longstreth Jr WT, Tirschwell DL. Editorial comment—The next 30 years of stroke for patients, providers, planners, and politicians. Stroke. 2003;34:2113.PubMedCrossRefGoogle Scholar
  13. 13.
    O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study. Lancet. 2010;376:112–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.PubMedCrossRefGoogle Scholar
  15. 15.
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol. 2010;7:369–75.PubMedCrossRefGoogle Scholar
  17. 17.
    Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.PubMedCrossRefGoogle Scholar
  19. 19.
    Kuklina EV, Tong X, George MG, Bansil P. Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother. 2012;12:199–208.PubMedCrossRefGoogle Scholar
  20. 20.
    Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke. 2003;34:2475–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Physical activity guidelines advisory committee report. US Dept of health and human services, Washington, DC. Available at http://www.Health.Gov/paguidelines/
  22. 22.
    Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis. 2009;18:185–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Furie KL, Goldstein LB, Albers GW, et al. Science Advisory: Oral Antithrombotic Agents for the Prevention of stroke in Nonvalvular Atrial Fibrillation, A Science Advisory for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2012;43:3442–3453.PubMedCrossRefGoogle Scholar
  24. 24.
    Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry. 2007;22:613–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the women’s health initiative study. Arch Intern Med. 2009;169:2128–39.PubMedCrossRefGoogle Scholar
  26. 26.
    Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen AH, Brady SM, Kase CS, et al. Depressive symptoms and risk of stroke: the Framingham study. Stroke. 2007;38:16–21.PubMedCrossRefGoogle Scholar
  27. 27.
    Johnston SC, Fayad PB, Gorelick PB, Hanley DF, Shwayder P, van Husen D, et al. Prevalence and knowledge of transient ischemic attack among US adults. Neurology. 2003;60:1429–34.PubMedCrossRefGoogle Scholar
  28. 28.
    Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6:1063–72.PubMedCrossRefGoogle Scholar
  30. 30.
    Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366:29–36.PubMedCrossRefGoogle Scholar
  31. 31.
    Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283–92.PubMedCrossRefGoogle Scholar
  32. 32.
    Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. The American academy of neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276–93.PubMedCrossRefGoogle Scholar
  33. 33.
    Ovbiagele B, Kidwell CS, Saver JL. Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke. 2003;34:919–24.PubMedCrossRefGoogle Scholar
  34. 34.
    Longstreth Jr WT, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O’Leary D, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the cardiovascular health study. Stroke. 2002;33:2376–82.PubMedCrossRefGoogle Scholar
  35. 35.
    Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–22.PubMedCrossRefGoogle Scholar
  36. 36.
    Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke. 2003;34:1581–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke. 2009;40:1032–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Guralnik JM, LaCroix AZ, Branch LG, Kasl SV, Wallace RB. Morbidity and disability in older persons in the years prior to death. Am J Public Health. 1991;81:443–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, et al. Sex differences in stroke care and outcomes: results from the registry of the Canadian stroke network. Stroke. 2005;36:809–14.PubMedCrossRefGoogle Scholar
  40. 40.
    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349:1498–504.PubMedCrossRefGoogle Scholar
  41. 41.
    Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA. Patient preferences for stroke outcomes. Stroke. 1994;25:1721–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D’Agostino RB, Wolf PA. The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis. 2003;12:119–26.PubMedCrossRefGoogle Scholar
  43. 43.
    Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation. 2008;118:576–85.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Neurological Institute Center for Outcomes Research & EvaluationCleveland ClinicClevelandUSA

Personalised recommendations